Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C500085
http://purl.bioontology.org/ontology/MESH/C500085
|
|---|---|
| Preferred Name | muraglitazar |
| Synonyms |
N-((4-methoxyphenoxy)carbonyl)-N-((4-(2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy)phenyl)methyl)glycine
BMS298585
BMS-298585
BMS 298585
Pargluva
2-((4-methoxyphenoxy)carbonyl-((4-(2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy)phenyl)methyl)amino)acetic acid
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel | N-((4-methoxyphenoxy)carbonyl)-N-((4-(2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy)phenyl)methyl)glycine
BMS298585
BMS-298585
BMS 298585
Pargluva
2-((4-methoxyphenoxy)carbonyl-((4-(2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy)phenyl)methyl)amino)acetic acid
See more
See less
|
|---|---|
| prefLabel | muraglitazar
|
| II |
D010643
D047493/Q000819
D047495/Q000819
|
| Scope Statement | has glucose- and lipid-lowering activities; structure in first source; molecule composed of benzyloxazole-phenoxy-oxybenzylglycine-phenoxyl having structural analogy to PHENOXYBENZAMINE
|
| type | |
| tui |
T116
T121
|
| Has mapping qualifier | |
| HM |
D010080
D005998/Q000031
|
| SC | 1
|
| TERMUI |
T638987
T657329
T638983
T638984
T638986
T638985
See more
See less
|
| TH |
NLM (2005)
FDA SRS (2013)
USAN (19XX)
INN (19XX)
|
| SRC | J Med Chem 2005 Mar 24;48(6):2148-50
|
| MMR | 20121105
|
| notation | C500085
|
| Semantic type UMLS property | |
| cui |
C1568491
C1568490
C1615022
|
| MeSH Frequency | 65
|
| LT | TRD
|
| DSC | 20050501
|
| Inverse of RB | W1MKM70WQI
|
| Mapped to | |
| MDA | 20050501
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |